Real world challenges and disparities in the systemic treatment of ovarian cancer

被引:3
|
作者
Nogueira-Rodrigues, Angelica [1 ,4 ]
Giannecchini, Giovanna Vieira [2 ]
Secord, Angeles Alvarez [3 ]
机构
[1] Fed Univ MG, Brazilian Grp Gynecol Oncol EVA, Latin Amer Cooperat Oncol Grp LACOG, Oncoclin,DOM Oncol, Pampulha, Brazil
[2] Oncoclinicas, Brasilia, Brazil
[3] Duke Univ Hlth Syst, Duke Canc Inst, Dept Obstet & Gynecol, Div Gynecol Oncol, Durham, NC USA
[4] Ave Prof Alfredo Balena 110,110 St Efigenia, BR-30130100 Belo Horizonte, MG, Brazil
关键词
Ovarian cancer care; Real world challenges; Disparities in access to treatment; GYNECOLOGIC CANCER; COUNTRIES;
D O I
10.1016/j.ygyno.2024.02.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ovarian cancer (OC) is a global health problem, and the mortality -to -incidence ratio is expected to increase, especially in low- and middle -income countries. These regions face disparities in access to OC care, including lack of awareness, limited access to genetic and tumor testing, paucity of surgical expertise, time to approval of novel therapeutics, and treatment costs. By addressing these inequities, the core aim of this paper is to promote action through collaboration in order to overcome these barriers and promote health equity in OC management and treatment. (c) 2024 Published by Elsevier Inc.
引用
收藏
页码:180 / 185
页数:6
相关论文
共 50 条
  • [31] Challenges for immunotherapy for the treatment of platinum resistant ovarian cancer
    Le Saux, Olivia
    Ray-Coquard, Isabelle
    Labidi-Galy, S. Intidhar
    SEMINARS IN CANCER BIOLOGY, 2021, 77 : 127 - 143
  • [32] Challenges to the Paclitaxel/Carboplatin Algorithm in Ovarian Cancer Treatment
    Zorn, Kristin K.
    ONCOLOGY-NEW YORK, 2010, 24 (08): : 738 - 740
  • [33] Using real-world cancer registration data to evaluate treatment rates for women with ovarian cancer in England - results from National ovarian cancer audit
    Zachou, Georgia
    Hutchings, Andrew
    Boudour, Joanne
    Gurol-Urganci, Ipek
    Van Der Meulen, Jan
    Michael, Agnieszka
    Sundar, Sudha
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A265 - A265
  • [34] Factors leading to racial disparities in treatment and outcomes of epithelial ovarian cancer
    Erickson, B.
    Martin, J.
    Shah, M.
    Fauci, J.
    Daily, L.
    Pasko, D.
    Walters, C.
    Leath, C.
    Straughn, J.
    GYNECOLOGIC ONCOLOGY, 2013, 131 (01) : 280 - 281
  • [35] Racial disparities in the surgical treatment of epithelial ovarian cancer in the United States
    Chan, John K.
    Zhang, Mallory
    Hu, Jessica
    Shin, Jacob Y.
    Husain, Amreen
    Teng, Nelson N.
    Berek, Jonathan S.
    Kapp, Daniel S.
    Osann, Kathryn
    GYNECOLOGIC ONCOLOGY, 2007, 104 (03) : S31 - S31
  • [36] Racial disparities in the surgical treatment of epithelial ovarian cancer in the United States
    Kapp, Daniel S.
    Hu, Jessica
    Shin, Jacob Y.
    Husain, Amreen
    Teng, Nelson N.
    Chan, Andjohn K.
    OBSTETRICS AND GYNECOLOGY, 2007, 109 (04): : 9S - 9S
  • [37] Sociodemographic Disparities in Advanced Ovarian Cancer Survival and Adherence to Treatment Guidelines
    Bristow, Robert E.
    Chang, Jenny
    Ziogas, Argyrios
    Campos, Belinda
    Chavez, Leo R.
    Anton-Culver, Hoda
    OBSTETRICS AND GYNECOLOGY, 2015, 125 (04): : 833 - 842
  • [38] Disparities in ovarian cancer treatment and overall survival according to race: An update
    Huffman, Deanna L.
    Jayakrishnan, Thejus Thayyil
    Shankar, Karthik
    Peterson, Chelsea E.
    Wegner, Rodney E.
    GYNECOLOGIC ONCOLOGY, 2021, 162 (03) : 674 - 678
  • [39] REAL WORLD TREATMENT PATTERNS OF PATIENTS WITH OVARIAN CANCER RECEIVING FIRST LINE CHEMOTHERAPY IN THE UNITED STATES
    Yu, N.
    Xiao, Y.
    Yi, J.
    Oliveri, D.
    Houghton, R.
    Luhn, P.
    VALUE IN HEALTH, 2017, 20 (09) : A473 - A473
  • [40] Real-world treatment patterns of maintenance therapy in platinum-sensitive recurrent ovarian cancer
    Moss, Haley A.
    Perhanidis, Jessica A.
    Havrilesky, Laura J.
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2021, 163 (01) : 50 - 56